Apogee Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: APGE · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1974640
| Field | Detail |
|---|---|
| Company | Apogee Therapeutics, Inc. (APGE) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: APGE
TL;DR
APGE filed an 8-K for a shareholder vote on 6/17. Standard governance.
AI Summary
Apogee Therapeutics, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders as of June 17, 2025. The company, incorporated in Delaware, is involved in biological products and is headquartered in Waltham, Massachusetts.
Why It Matters
This filing indicates that Apogee Therapeutics held a vote of its security holders, which is a standard corporate governance event that can signal important decisions or approvals.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for a shareholder vote, which typically does not involve significant new financial or operational risks.
Key Players & Entities
- Apogee Therapeutics, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- June 23, 2025 (date) — Date of report
- Waltham, Massachusetts (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Apogee Therapeutics' security holders?
The filing does not specify the exact matters submitted to a vote, only that such matters were reported on as of June 17, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 17, 2025.
What is the principal business of Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. is involved in Biological Products (No Diagnostic Substances).
Where is Apogee Therapeutics, Inc. headquartered?
The company's principal executive offices are located at 221 Crescent St., Bldg 17, Suite 102b, Waltham, Massachusetts, 02453.
What is the Commission File Number for Apogee Therapeutics, Inc.?
The Commission File Number for Apogee Therapeutics, Inc. is 001-41740.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Apogee Therapeutics, Inc. (APGE).